ArticleMolecular neurobiology2026
β-hydroxybutyrate Modulates Neuroinflammatory Responses and Astrocyte Reactivity in an In Vitro Model of Traumatic Brain Injury.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The ketogenic diet has attracted increasing interest for its potential neuroprotective effects, mediated by β-hydroxybutyrate (BHB), a ketone body influencing energy metabolism and inflammation. This study examined whether BHB supplementation modulates cellular responses to injury in an in vitro scratch model of traumatic brain injury (TBI). Primary cortical and hippocampal neuron-glia cultures derived from neonatal rats were maintained for 21 days in vitro (DIV). Cultures were supplemented with 5 mM BHB from DIV14 to DIV21. At DIV21, mechanical scratch injury was applied, and cellular responses were assessed 6 h and 24 h post-injury using live-cell migration imaging, Western blotting (GFAP, NeuN), cytokine profiling, immunocytochemistry, and electron microscopy. BHB supplementation was associated with increased astrocyte density in injured cortical and hippocampal cultures and with shifts in astrocyte morphology toward bipolar and intermediate phenotypes, suggesting modulation of astrocyte reactivity. In BHB-supplemented cortical cultures, neuronal density within the injury area was higher compared with non-supplemented controls. BHB reduced levels of the pro-inflammatory cytokine IL-1β and modulated the expression profiles of GM-CSF, IFNγ, and Neuropilin-1, in a region- and time-dependent manner. GFAP expression in hippocampal cultures displayed a biphasic response, indicating dynamic astrocyte regulation following injury. Ultrastructural analysis revealed injury-induced cellular alterations, while BHB-supplemented cultures exhibited features consistent with improved cellular integrity. Collectively, these findings suggest that BHB modulates astrocyte-associated inflammatory responses and supports cellular adaptation following mechanical injury in neuron-glia cultures. While limited to an in vitro setting, this study provides insight into potential mechanisms by which BHB may influence neuroinflammatory processes after TBI.
Indexed as
Identifiers
41795770What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.